Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Cardiology Reports
Published in: Current Cardiology Reports 6/2015

01-06-2015 | Diabetes and Cardiovascular Disease (S Malik, Section Editor)

Impact of Functional Foods on Prevention of Cardiovascular Disease and Diabetes

Authors: Geeta Sikand, Penny Kris-Etherton, Nancy Mariam Boulos

Published in: Current Cardiology Reports | Issue 6/2015

Login to get access

Abstract

A healthy dietary pattern is a cornerstone for the prevention and treatment of cardiovascular disease (CVD) and type 2 diabetes (T2DM). Compelling scientific evidence has shown many health effects of individual foods (including herbs and spices), beverages, and their constituent nutrients and bioactive components on risk of chronic disease and associated risk factors. The focus of functional foods research that is reviewed herein has been on assessing the health effects and underlying mechanisms of action of fruits and vegetables, whole grains, dairy products including fermented products, legumes, nuts, green tea, spices, olive oil, seafood, red wine, herbs, and spices. The unique health benefits of these functional foods have been the basis for recommending their inclusion in a healthy dietary pattern. A better understanding of strategies for optimally including functional foods in a healthy dietary pattern will confer greater benefits on the prevention and treatment of CVD and T2DM.
Literature
1.
2.
Chen G, Wang H, Zhang X, Yang S. Nutraceuticals and functional foods in the management of hyperlipidemia. Crit Rev Food Sci Nutr. 2014;54:1180–201.PubMed
3.
Oh YS, Jun HS. Role of bioactive food components in diabetes prevention: effects on beta-cell function and preservation. Nutrit Metabol Insights. 2014;7:51–9.
4.•
Position of the Academy of Nutrition and Dietetics: Functional Foods J Acad Nutr Diet 2013;113:1096–1103. This position paper provides a definition of functional foods and the regulatory overview that requires significant substantiation of functional foods.
5.••
Mirmiran P, Bahadoran Z, Azizi F. Functional foods-based diets a novel dietary approach for management of type 2 diabetes and its complications: a review. World J Diab. 2014;5(3):267–81. This review article provides a comprehensive review of the prevention of diabetes with functional foods based diets.
6.
7.
Ross S. Functional foods: the food and drug administration perspective. Am J Clin Nutr. 2000;71(6 suppl):1735S–8S.PubMed
8.
9.
10.
11.
Borneo R, Leon AE. Whole grain cereals: functional components and health benefits. Food Funct. 2012;3:110–9.PubMed
12.
Ye EQ, Chacko SA, Chou EL, Kugizaski M, et al. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease and weight gain. J Nutr. 2012;142:1304–13.PubMed
13.
Okarter N, Liu RH. Health benefits of whole grain phytochemicals. Crit Rev Good Sci Nutr. 2010;50:193–20.
14.
Anderson A, Tengblad S, Karlstrom B, Kamal-Eldin A, et al. Whole grain foods do not affect insulin sensitivity or markers of lipid peroxidations and inflammation in healthy, moderately overweight subjects. J Nutr. 2007;137:1401–7.
15.
Martinez IM, Lattimer JM, Hubach KL, Case JA, et al. Gut microbiome composition is linked to whole grain induced immunological improvements. ISME J. 2013;7:269–80.PubMedCentralPubMed
16.
Cho S, Lu Q, Fahey GC, Klurfeld DM. Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease. Am J Clin Nutr. 2013;98:594–619.PubMed
17.
18.
He M, Van Dam RN, Rimm E, Hu FB, et al. Whole-grain, cereal fiber, bran, and germ intake and the risks of all-cause and cardiovascular disease-specific mortality among women with type 2 diabetes mellitus. Circulation. 2010;121:2162–8.PubMedCentralPubMed
19.
Toh JY, Tan VM, Lim PC, Lim ST, Chong MF. Flavonoids from fruit and vegetables: a focus on cardiovascular risk factors. Curr Atheroscler Rep. 2013;15(12):368.PubMed
20.
Chawla R, Patil GR. Soluble dietary fiber. Compr Rev Food Sci Food Saf. 2010;9(2):178–96.
21.
Raninen K, Lappi J, Mykkanen H, Poutanen K. Dietary fiber type reflects physiological functionality: comparison of grain fiber, inulin and polydextrose. Nutr Rev. 2011;60(1):9–21.
22.
Viuda-martos M, Sanchez-zapata E, Sayas-barberá E, Sendra E, Pérez-Álvarez JA, Fernández-lópez J. Tomato and tomato byproducts. Human health benefits of lycopene and its application to meat products: a review. Crit Rev Food Sci Nutr. 2014;54(8):1032–49.PubMed
23.
Muller FO. Re: The grapefruit: an old wine in a new glass? Metabolic and cardiovascular perspectives. Cardiovasc J Afr. 2011;22(1):37.PubMedCentralPubMed
24.
Takahashi K, Kamada C, Yoshimura C, Okumura R, et al. Effects of total and green vegetable intakes on glycated hemoglobin A1c and triglycerides in elderly patients with type 2 diabetes mellitus: the Japanese Elderly Intervention Trial. Geriatr Gerontol Int. 2012;12 Suppl 1:50–8.PubMed
25.
Hegde SV, Adhikari PMN, D’Souza V. Effect of daily supplementation of fruits on oxidative stress indices and glycemic status in type 2 diabetes mellitus. Complem Ther Clin Pract. 2013;19:97–100.
26.
Tanaka S, Yoshimura Y, Kawasaki R, Kamada C, et al. Fruit intake and incident diabetic retinopathy with type 2 diabetes. Epidemiology. 2013;24:204–11.PubMed
27.
Chan HT, Yiu KH, Wong CY, Li SW, et al. Increased dietary fruit intake was associated with lower burden of carotid atherosclerosis in Chinese patients with type 2 diabetes mellitus. Diabet Med. 2013;30:100–8.PubMed
28.
Yang J, Xiao YY. Grape phytochemicals and associated health benefits. Crit Rev Food Sci Nutr. 2013;53(11):1202–25.PubMed
29.
Stowe CB. The effects of pomegranate juice consumption on blood pressure and cardiovascular health. Complement Ther Clin Pract. 2011;17(2):113–5.PubMed
30.
Ismail T, Sestilli P, Akhtar S. Pomogranate peel and fruit extracts: a review of potential anti-inflammatory and anti-infective effects. J Ethnopharmacol. 2012;143(2):397–405.PubMed
31.
Bondonno CP, Yang X, Croft KD, et al. Flavonoid rich apples and nitrate-rich spinach augment nitric oxide status and improve endothelial function in healthy men and women: a randomized controlled trial. Free Radic Ciol Med. 2012;52(1):95–102.
32.
Sirtori CR, Galli C, Anderson JW, Arnoldi A, et al. Nutritional and neutraceutical approaches to dyslipidemia and atherosclerosis prevention: focus on dietary proteins. Atherosclerosis. 2009;203(1):8–17.PubMed
33.
Flight I, Clifton P. Cereal grains and legumes in the prevention of coronary heart dz & stroke: a review of the literature. Eur J Clin Nutr. 2006;60:1145–59.PubMed
34.
Duranti M. Grain legume proteins and nutraceutical properties. Fitoterapia. 2006;77:67–82.PubMed
35.
Barrett MI, Udani JK. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clincal studies on weight loss and glycemic control. Nutr J. 2011;10:24.PubMedCentralPubMed
36.
Yao Y, Cheng XZ, Wang LX, Wang SH, et al. Major phenolic compounds, antioxidant capacity and antidiabetic potential of rice bean (Vigna umbellata L.) in China. In J Mol Sci. 2012;13:2707–16.
37.
Helmstadter A. Beans and diabetes: Phenolus vulgaris preparation as antihypertensive agents. J Med Food. 2010;13:251–4.PubMed
38.
Preuss HG. Bean amylase inhibitor and other carbohydrate absorption blockers effects on diabesity and general health. J Am Coll Nutr. 2009;28:266–76.PubMed
39.
Thompson SV, Winham DM, Hutchins AM. Bean and rice meals reduce postprandial glycemic responses in adults with type 2 diabetes: a crossover study. Nutr J. 2012;11:23.PubMedCentralPubMed
40.
Weisse K, Brandsch C, Zernsdorf B, Nembongwe G, et al. Lupin protein compared to casein lowers the LDL-Cholesterol:HDL-Cholesterol ratio of hypercholesterolemic adults. Eur J Nutr. 2010;49(2):65–71.PubMed
41.
Gilbert ER, Liu D. Anti-diabetic functions of soy isoflavone genistein: mechanism underlying its effects on pancreatic beta-cell function. Food Fnct. 2013;4:200–12.
42.
Anderson JW, Bush HM. Soy protein effects on serum lipoproteins: a quality assessment and meta analysis of randomized, controlled studies. J Am Coll Nutr. 2011;30:79–91.PubMed
43.
Azadbakht L, Shakerhosseini R, Atabak S, Jamshidian M, et al. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type 2 diabetes with nephropathy. Eur J Clin Nutr. 2003;57:1292–4.PubMed
44.
Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr. 2002;76:1191–201.PubMed
45.
Yang B, Chen Y, Xu T, Yu Y, et al. Systematic review and meta-analysis of soy products consumption in patients with type 2 diabetes mellitus. Asia Pac J Clin Nutr. 2011;20:593–602.PubMed
46.
Ronis MJ, Chen Y, Badeaus J, Badger TM. Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR and SREBP signaling. J Nutr. 2009;139:1431–8.PubMed
47.
Liu CF, Pan TM. Beneficial Effects of Bioactive Peptides derived from Soybean on Human Health and Their Production by Genetic Engineering. Soybean and health 2011;311–329.
48.
Anderson JW, Bush HM. Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies. J Am Coll Nutr. 2011;30:2,79–91.
49.
Harland JI, Haffner TA. Systematic review, meta-analysis and regression of randomized controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol. Atherosclerosis. 2008;200:13–27.PubMed
50.
Afshin A, Micha R, Khatibzadeh S, Mozaffarian D. Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis. Am J Clin Nutr. 2014;100:278–88.PubMed
51.
Kendall CW, Esfahani A, Truan J, Srichaikul K, et al. Health benefits of nuts in prevention and management of diabetes. Asia Pac J Clin Nutr. 2010;19:110–6.PubMed
52.
Ross E. Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr. 2009;89:1649S–56S.
53.
Jenkins DJ, Hu FB, Tapsell LC, Josse AR, et al. Possible benefits of nuts in type 2 diabetes. J Nutr. 2008;138:1752S–6S.PubMed
54.
Li TY, Brennan AM, Wedick NM, Mantzoros C, et al. Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes. J Nutr. 2009;139:1333–8.PubMedCentralPubMed
55.
Tey SL, Brown R, Gray A, Chisholm A, et al. Nuts improve diet quality compared to other energy dense snacks while maintaining body weight. J Nutr Metab. 2011;2011:357350.PubMedCentralPubMed
56.
Mattes RD, Dreher ML. Nuts and healthy body weight maintenance mechanisms. Asia Pac J Clin Nutr. 2010;19:137–41.PubMed
57.
Mantzoros CS, Williams CJ, Manson JE, Meigs JB, et al. Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am J Clin Nutr. 2006;84:328–35.PubMed
58.
Jiang R, Jacobs DR, Mayer-Davis E, Szklo M, et al. Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2006;163:222–31.PubMed
59.
Ross E. Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr. 2009;89:1649S–56S.
60.•
Bao U, Han J, Hu FG, Stampfer M, Willett W, Fuchs CS. Association of nut consumption with total and cause specific mortality. N Engl J Med. 2013;369:2001–11. In two major cohort studies (Nurses’ Health Study and the Health Professionals Follow-up Study), the frequency of nut consumption was inversely associated with total and cause-specific mortality in a dose-dependent manner. Nut consumption (seven or more times per week) resulted in a 20 % lower death rate. PubMedCentralPubMed
61.
Wang ZM, Zhou B, Wang YS, Gong Q et al. Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr. 93 (3):506–515.
62.
Jiao H, Hu G, Gu D, Ni X. Having a Promising Efficacy on Type II diabetes, It’s definitely a green tea time. Curr Med Chem. 2014.
63.
Takahashi M, Miyashita M, Suzuki K, et al. Acute ingestion of catechin-rich green tea improves postprandial glucose status and increases serum thioredoxin concentrations in postmenopausal women. Br J Nutr. 2014:1–9.
64.
Zuo X, Tian C, Zhao N, Ren W, et al. Tea polyphenols alleviate high fat and high glucose-induced endothelial hyper permeability by attenuating ROS production via NADPH oxidase pathway. BMC Res Notes. 2014;7:120.PubMedCentralPubMed
65.
Grassi D, Desideri G, Ferri C. Protective effects of dark chocolate on endothelial function and diabetes. Curr Opin Clin Nutr Metab Care. 2013;16(6):662–8.PubMed
66.
Katz DL, Doughty K, Ali A. Cocoa and chocolate in human health and disease. Antioxid Redox Signal. 2011;15(10):2779–811.PubMed
67.
Buitrago-Lopez A, Sanderson J, Johnson L, Warnakula S, et al. Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ. 2011;343:d4488.PubMedCentralPubMed
68.
Messerli FH. Chocolate consumption, cognitive function, and nobel laureates. N Engl J Med. 2012;367:1562–4.PubMed
69.
Fernández-Murga L, Tarín JJ, García-Perez MA, Cano A. The impact of chocolate on cardiovascular health. Maturitas. 2011;69:312–21.PubMed
70.
Eilat-adar S, Sinai T, Yosefy C, Henkin Y. Nutritional recommendations for cardiovascular disease prevention. Nutrients. 2013;5(9):3646–83.PubMedCentralPubMed
71.
Kwon MJ, Song YS, Choi MS, Park S et al. Cholesteryl ester transfer protein activity and atherogenic parametes in rabbits supplemented with cholesterol and garlic powder. Life Sci. 72(26):2953–2964.
72.
Khoo YS, Aziz Z. Garlic supplementation and serum cholesterol: a meta-analysis. J Clin Pharm Ther. 2009;34:133–45.PubMed
73.
Ackermann RT, Mulrow CD, Ramirez G, Gardner CD. Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med. 2001;161:813–24.PubMed
74.
Zeb I, Ahmadi N, Nasir K, Kadakia J, Larijani VN, Flores F, et al. Aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: a randomized clinical trial. J Cardiovasc Dis Res. 2012;3(3):185–90. doi:10.​4103/​0975-3583.​98883.PubMedCentralPubMed
75.
Qin B, Panickar KS, Anderson RA. Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes. J Diabetes Sci Technol. 2010;4(3):685–93.PubMedCentralPubMed
76.
Crawford P. Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med. 2009;22(5):507–12.PubMed
77.
78.
Smith JD, Clinard VB. Natural products for the management of type 2 diabetes mellitus and comorbid conditions. J Am Pharm Assoc. 2014;54(5):e304–20.
79.
Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res. 2014;28(5):633–42.PubMed
80.
Neelakantan N, Narayanan M, de Souza RJ, et al. Effect of fenugreek (Trigonella foenum-graecum L) intake on glycemia: a meta-analysis of clinical trials. Nutr J. 2014;13:7.PubMedCentralPubMed
81.
Liu Y, Kakani R, Nair MG. Compounds in functional food fenugreek spice exhibit anti-inflammatory and antioxidant activities. Food Chem. 2012;3:1187–92.
82.
Mandegary A, Pournamdari M, Sharififar F, Pournourmohammadi S, Fardiar R, Shooli S. Alkaloid and flavonoid rich fractions of fenugreek seeds (Trigonella foenum-graecum L.) with antinociceptive and anti-inflammatory effects. Food Chem Toxicol. 2012;50(7):2503–7.PubMed
83.
Elwood P, Pickering J, Givens DI, Gallacher J. The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids. 2010;45(10):925–39.PubMedCentralPubMed
84.
Soedamah-Muthu SS, Ding EL, Al-Delaimy WK, Hu FB, Engberink MF, Willett WC, et al. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose–response meta-analysis of prospective cohort studies. Am J Clin Nutri. 2011;93(1):158–71.
85.
Sonestedt E, Wirfält E, Wallström P, Gullberg B, Orho-Melander M, Hedblad B. Dairy products and its association with incidence of cardiovascular disease: the Malmö diet and cancer cohort. Eur J Epidemiol. 2011;26(8):609–18.PubMed
86.
Patterson E, Larsson SC, Wolk A, Åkesson A. Association between dairy food consumption and risk of myocardial infarction in women differs by type of dairy food. J Nutri. 2013;143(1):74–9.
87.
de Oliveira Otto MC, Nettleton JA, Lemaitre RN, Steffen LM, Kromhout D, Rich SS, et al. Biomarkers of dairy fatty acids and risk of cardiovascular disease in the multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2013;2(4):e000092.PubMedCentralPubMed
88.
Mann GV, Spoerry A. Studies of a surfactant and cholesteremia in the Maasai. Am J Clin Nutri. 1974;27(5):464–9.
89.
de Roos NM, Schouten G. Yoghurt enriched with Lactobacillus acidophilus does not lower blood lipids in healthy men and women with normal to borderline high serum cholesterol levels. Eur J Clin Nutr. 1999;53(4):277–80.PubMed
90.
Lewis SJ, Burmeister S. A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids. Eur J Clin Nutr. 2005;59(6):776–80.PubMed
91.
Simons LA, Amansec SG, Conway P. Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutr Metab Cardiovasc Dis. 2006;16(8):531–5.PubMed
92.
Ataie-Jafari A, Larijani B, Alavi Majd H, Tahbaz F. Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Ann Nutr Metab. 2009;54(1):22–7.PubMed
93.
Xiao JZ, Kondo S, Takahashi N, Miyaji K, Oshida K, Hiramatsu A, et al. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci. 2003;86(7):2452–61.PubMed
94.
Anderson JW. Effect of fermented milk (yogurt) containing lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr. 1999;18(1):43–50.PubMed
95.
Guo Z, Liu XM, Zhang QX, Shen Z, Tian FW, Zhang H, et al. Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis. 2011;21(11):844–50.PubMed
96.
Agerholm L, Bell ML. The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies. Eur J Clin Nutr. 2000;54(11):856.
97.
DiRienzo DB. Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets. Nutr Rev. 2014;72(1):18–29.PubMed
98.•
Jakobsen MU, O’Reilly EJ, Heitmann BL, Pereira MA, Bälter K, Fraser GE, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89(5):1425–32. Results from 11 American and European cohort pooled studies (with 344,696 participants) demonstrated that replacing saturated fatty acids with polyunsaturated fatty acids rather than monounsaturated fatty acids or dietary carbohydrate prevents CHD. PubMedCentralPubMed
99.
Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169(7):659–69.PubMed
100.
Skeaff CM, Miller J. Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutri Metab. 2009;55(1–3):173–201.
101.
Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk a systematic review and meta-analysis. Ann Intern Med. 2014;160(6):398–406.PubMed
102.
Schwingshackl L, Hoffmann G. Monounsaturated fatty acids and risk of cardiovascular disease: synopsis of the evidence available from systematic reviews and meta-analyses. Nutrients. 2012;4(12):1989–2007.PubMedCentralPubMed
103.•
Guasch-Ferre M, Hu F, Martinez-Gonzalez M, Fito M, Bullo M, Estruch R, et al. Olive oil intake and risk of cardiovascular disease and mortality in the PREDIMED study. BMC Med. 2014;12(1):78. In this study, for every 10 g/day increase in extra-virgin olive oil consumed, risk of cardiovascular disease and mortality decreased by 10 % and 7 %, respectively. PubMedCentralPubMed
104.
Buckland G, Mayén AL, Agudo A, Travier N, Navarro C, Huerta JM, et al. Olive oil intake and mortality within the Spanish population (EPIC-Spain). Am J Clin Nutr. 2012;96(1):142–9.PubMed
105.
Samieri C, Feart C, Proust-Lima C, Peuchant E, Tzourio C, Stapf C, et al. Olive oil consumption, plasma oleic acid, and stroke incidence: the Three-City Study. Neurology. 2011;77(5):418–25.PubMed
106.
Martínez-González MA, Dominguez LJ, Delgado-Rodríguez M. Olive oil consumption and risk of CHD and/or stroke: a meta-analysis of case–control, cohort and intervention studies. Br J Nutr. 2014;112(02):248–59.PubMed
107.
Schwingshackl L, Hoffmann G. Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies. Lipids Health Dis. 2014;13(1):154.PubMedCentralPubMed
108.
Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, de Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation. 2002;105(24):2836–44.PubMed
109.
Li H, Förstermann U. Red wine and cardiovascular health. Circ Res. 2012;111(8):959–61.PubMed
110.
Chiva-Blanch G, Urpi-Sarda M, Ros E, Arranz S, Valderas-Martínez P, Casas R, et al. Dealcoholized red wine decreases systolic and diastolic blood pressure and increases plasma nitric oxide: short communication. Circ Res. 2012;111(8):1065–8.PubMed
111.
Krnic M, Modun D, Budimir D, Gunjaca G, Jajic I, Vukovic J, et al. Comparison of acute effects of red wine, beer and vodka against hyperoxia-induced oxidative stress and increase in arterial stiffness in healthy humans. Atherosclerosis. 2011;218(2):530–5.PubMed
112.
Costanzo S, Di Castelnuovo A, Donati M, Iacoviello L, de Gaetano G. Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis. Eur J Epidemiol. 2011;26(11):833–50.PubMed
113.
Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in north western Greenland. Am J Clin Nutr. 1980;33(12):2657–61.PubMed
114.
Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296(15):1885–99.PubMed
115.
Mozaffarian D, Lemaitre RN, King IB, Song X, Huang H, Sacks FM, et al. Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults a cohort study. Ann Intern Med. 2013;158(7):515–25.PubMedCentralPubMed
116.
Wu JHY, Lemaitre RN, King IB, Song X, Sacks FM, Rimm EB, et al. Association of plasma phospholipid long-chain omega-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Circulation. 2012;125(9):1084–93.PubMedCentralPubMed
117.
Djoussé L, Akinkuolie AO, Wu JHY, Ding EL, Gaziano JM. Fish consumption, omega-3 fatty acids and risk of heart failure: a meta-analysis. Clin Nutr. 2012;31(6):846–53.PubMedCentralPubMed
118.
Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105(16):1897–903.PubMed
119.
Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369(9567):1090–8.PubMed
120.
Harris WS. Are n-3 fatty acids still cardioprotective? Curr Opin Clin Nutr Metab Care. 2013;16(2):141–9.PubMed
121.
U.S. Department of Agriculture and U.S. Department of Health and Human Services. USDA H. dietary guidelines for Americans 2010. 7th ed. Washington, DC: US Government Printing Office; 2010.
122.
Spencer JPE, Gozier A. Flavonoids and related compounds. In: Paker L, Cardenas H, editors. Bioavaialability and function. oxidative stress and disease, vol 30. Boca Raton: CRG Press; 2012.
123.
Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M,Borges G, Crozier A. Dietary polyphenolics in Human Health: Atructures, Bioavailabity and Evidence of Protective Effects against Chronic Diseases. 2013 Antioxidants and Redox Signaling 18, 14:1818–92.
124.
Reedy J, Krebs-Smith SM, Miler PE, Liese A, et al. Higher diet quality is associated with decreased risk of all-cause. Cardiovascular disease, and cancer mortality among older adults. J Nutr. 2014;144:881–9.PubMed
125.
126.
Grundy SM, Arai H, Barter P, Bersot TP et al. 2013. An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia www.​athero.​org (accessed September 20, 2014).
127.
128.
Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, et al. National lipid association recommendations for patient-centered management of dyslipidemia: part 1—executive summary. J Clin Lipidol. 2014;8:473–88.PubMed
129.
Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diab Care. 2014;37 Suppl 1:S120–43. doi:10.​2337/​dc14-S120.
130.
Metadata
Title
Impact of Functional Foods on Prevention of Cardiovascular Disease and Diabetes
Authors
Geeta Sikand
Penny Kris-Etherton
Nancy Mariam Boulos
Publication date
01-06-2015
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 6/2015
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-015-0593-9

Other articles of this Issue 6/2015

Current Cardiology Reports 6/2015 Go to the issue

Echocardiography (JM Gardin, Section Editor)

Stress Echocardiography: What Is New and How Does It Compare with Myocardial Perfusion Imaging and Other Modalities?

Cardiac PET, CT, and MRI (SE Petersen, Section Editor)

New Insights from Major Prospective Cohort Studies with Cardiovascular Magnetic Resonance (CMR)

New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

The Evolution of Temporary Percutaneous Mechanical Circulatory Support Devices: a Review of the Options and Evidence in Cardiogenic Shock

Interventional Cardiology (S Rao, Section Editor)

Achieving Safe Femoral Arterial Access

Interventional Cardiology (S Rao, Section Editor)

Post-PCI Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation

Interventional Cardiology (S Rao, Section Editor)

Transradial Sheathless Approach for PCI

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits